Pharmaceuticals in Indonesia
Pharmaceuticals in Indonesia
SUMMARY
Pharmaceuticals in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Indonesian pharmaceuticals market had total revenues of $7,861.5m in 2019, representing a compound annual growth rate (CAGR) of 9.6% between 2015 and 2019.
- The growth of the Indonesian pharmaceutical market is largely driven by the Universal Health Coverage scheme (Jaminan Kesehatan Nasional, JKN), which prioritizes the use of generics.
- There is a rising incidence of chronic diseases such as diabetes and weight-associated cardiovascular disease, due to the country’s growing middle class, which is also driving growth within the market.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Indonesia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Indonesia
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Indonesia pharmaceuticals market with five year forecasts
- What was the size of the Indonesia pharmaceuticals market by value in 2019?
- What will be the size of the Indonesia pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the Indonesia pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Indonesia's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. Are there any opportunities for leading players?
8 COMPANY PROFILES
8.1. PT Kalbe Farma Tbk
8.2. Sanofi SA
8.3. Novartis AG
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. Are there any opportunities for leading players?
8 COMPANY PROFILES
8.1. PT Kalbe Farma Tbk
8.2. Sanofi SA
8.3. Novartis AG
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Indonesia pharmaceuticals market value: $ billion, 2015-19
Table 2: Indonesia pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Indonesia pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Indonesia pharmaceuticals market share: % share, by value, 2019
Table 5: PT Kalbe Farma Tbk: key facts
Table 6: PT Kalbe Farma Tbk: Annual Financial Ratios
Table 7: PT Kalbe Farma Tbk: Key Employees
Table 8: Sanofi SA: key facts
Table 9: Sanofi SA: Annual Financial Ratios
Table 10: Sanofi SA: Key Employees
Table 11: Sanofi SA: Key Employees Continued
Table 12: Novartis AG: key facts
Table 13: Novartis AG: Annual Financial Ratios
Table 14: Novartis AG: Annual Financial Ratios (Continued)
Table 15: Novartis AG: Key Employees
Table 16: Novartis AG: Key Employees Continued
Table 17: Indonesia size of population (million), 2015-19
Table 18: Indonesia gdp (constant 2005 prices, $ billion), 2015-19
Table 19: Indonesia gdp (current prices, $ billion), 2015-19
Table 20: Indonesia inflation, 2015-19
Table 21: Indonesia consumer price index (absolute), 2015-19
Table 22: Indonesia exchange rate, 2015-19
Table 1: Indonesia pharmaceuticals market value: $ billion, 2015-19
Table 2: Indonesia pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Indonesia pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Indonesia pharmaceuticals market share: % share, by value, 2019
Table 5: PT Kalbe Farma Tbk: key facts
Table 6: PT Kalbe Farma Tbk: Annual Financial Ratios
Table 7: PT Kalbe Farma Tbk: Key Employees
Table 8: Sanofi SA: key facts
Table 9: Sanofi SA: Annual Financial Ratios
Table 10: Sanofi SA: Key Employees
Table 11: Sanofi SA: Key Employees Continued
Table 12: Novartis AG: key facts
Table 13: Novartis AG: Annual Financial Ratios
Table 14: Novartis AG: Annual Financial Ratios (Continued)
Table 15: Novartis AG: Key Employees
Table 16: Novartis AG: Key Employees Continued
Table 17: Indonesia size of population (million), 2015-19
Table 18: Indonesia gdp (constant 2005 prices, $ billion), 2015-19
Table 19: Indonesia gdp (current prices, $ billion), 2015-19
Table 20: Indonesia inflation, 2015-19
Table 21: Indonesia consumer price index (absolute), 2015-19
Table 22: Indonesia exchange rate, 2015-19
LIST OF FIGURES
Figure 1: Indonesia pharmaceuticals market value: $ billion, 2015-19
Figure 2: Indonesia pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Indonesia pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Indonesia, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Indonesia, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Indonesia, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Indonesia, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Indonesia, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Indonesia, 2019
Figure 10: Indonesia pharmaceuticals market share: % share, by value, 2019
Figure 1: Indonesia pharmaceuticals market value: $ billion, 2015-19
Figure 2: Indonesia pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Indonesia pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Indonesia, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Indonesia, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Indonesia, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Indonesia, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Indonesia, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Indonesia, 2019
Figure 10: Indonesia pharmaceuticals market share: % share, by value, 2019
